Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Standard
Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis. / Ghazanfar, Misbah Noshela; Thomsen, Simon Francis.
I: Journal of Dermatological Treatment, Bind 30, Nr. 4, 2019, s. 387-388.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis
AU - Ghazanfar, Misbah Noshela
AU - Thomsen, Simon Francis
PY - 2019
Y1 - 2019
N2 - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.
AB - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.
KW - Omalizumab
KW - combined biologic therapy
KW - etanercept
KW - CSU
U2 - 10.1080/09546634.2018.1515465
DO - 10.1080/09546634.2018.1515465
M3 - Journal article
C2 - 30132352
VL - 30
SP - 387
EP - 388
JO - Journal of Dermatological Treatment
JF - Journal of Dermatological Treatment
SN - 0954-6634
IS - 4
ER -
ID: 227694325